Request Demo
Last update 09 Oct 2025
Human umbilical cord mesenchymal stem cells(Shandong Qilu Stem Cells)
Last update 09 Oct 2025
Overview
Basic Info
Drug Type Mesenchymal stem cell therapy |
Synonyms- |
Target- |
Action- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with Human umbilical cord mesenchymal stem cells(Shandong Qilu Stem Cells)NCT07201233
Clinical Study on the Safety and Efficacy of Unrelated Umbilical Cord Blood Infusion in Treating Bone Marrow Suppression After Chemotherapy in Elderly Patients With Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) .
NCT05794425
A Multicenter Collaborative Clinical Study of Umbilical Cord Blood Combined With Umbilical Cord Derived Mesenchymal Stem Cells in the Treatment of Bone Marrow Failure Disorders
NCT04882683
Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis
100 Clinical Results associated with Human umbilical cord mesenchymal stem cells(Shandong Qilu Stem Cells)
Login to view more data
100 Translational Medicine associated with Human umbilical cord mesenchymal stem cells(Shandong Qilu Stem Cells)
Login to view more data
100 Patents (Medical) associated with Human umbilical cord mesenchymal stem cells(Shandong Qilu Stem Cells)
Login to view more data
100 Deals associated with Human umbilical cord mesenchymal stem cells(Shandong Qilu Stem Cells)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anemia, Aplastic | Phase 2 | China | 01 Aug 2023 | |
| Decompensated cirrhosis of liver | Phase 2 | - | 01 Jun 2018 | |
| Alzheimer Disease | Phase 1 | China | 31 Jul 2025 | |
| Acute Myeloid Leukemia | Clinical | - | 01 Nov 2025 | |
| Bone marrow depression | Clinical | - | 01 Nov 2025 | |
| Myelodysplastic Syndromes | Clinical | - | 01 Nov 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free